You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

DICLOFENAC POTASSIUM Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Diclofenac Potassium patents expire, and when can generic versions of Diclofenac Potassium launch?

Diclofenac Potassium is a drug marketed by Aurobindo Pharma Ltd, Bionpharma, Strides Pharma, Alkem Labs Ltd, Annora Pharma, Endo Operations, Taro, Chartwell Rx, Novast Labs, Rk Pharma, Rubicon, Senores Pharms, Sun Pharm Industries, Teva, Umedica, and Watson Labs Teva. and is included in sixteen NDAs.

The generic ingredient in DICLOFENAC POTASSIUM is diclofenac potassium. There are forty-seven drug master file entries for this compound. Forty-two suppliers are listed for this compound. Additional details are available on the diclofenac potassium profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Diclofenac Potassium

A generic version of DICLOFENAC POTASSIUM was approved as diclofenac potassium by TEVA on August 6th, 1998.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for DICLOFENAC POTASSIUM?
  • What are the global sales for DICLOFENAC POTASSIUM?
  • What is Average Wholesale Price for DICLOFENAC POTASSIUM?
Drug patent expirations by year for DICLOFENAC POTASSIUM
Drug Prices for DICLOFENAC POTASSIUM

See drug prices for DICLOFENAC POTASSIUM

Paragraph IV (Patent) Challenges for DICLOFENAC POTASSIUM
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
ZIPSOR Capsules diclofenac potassium 25 mg 022202 1 2012-11-14
CAMBIA Oral Solution (Sachet) diclofenac potassium 50 mg 022165 1 2011-01-24

US Patents and Regulatory Information for DICLOFENAC POTASSIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Ltd DICLOFENAC POTASSIUM diclofenac potassium CAPSULE;ORAL 213875-001 Oct 19, 2021 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Watson Labs Teva DICLOFENAC POTASSIUM diclofenac potassium TABLET;ORAL 075152-001 Nov 27, 1998 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Taro DICLOFENAC POTASSIUM diclofenac potassium FOR SOLUTION;ORAL 218011-001 Jun 14, 2024 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Alkem Labs Ltd DICLOFENAC POTASSIUM diclofenac potassium FOR SOLUTION;ORAL 216635-001 Jul 20, 2022 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Rubicon DICLOFENAC POTASSIUM diclofenac potassium TABLET;ORAL 075229-001 Nov 20, 1998 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Chartwell Rx DICLOFENAC POTASSIUM diclofenac potassium TABLET;ORAL 075582-001 Feb 23, 2001 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.